340B Drug Pricing Program

January 27, 2023 Emeka Egwim, PharmD, RPh LCDR U.S. Public Health Service Director Office of Pharmacy Affairs Health Resources and Services Administration 5600 Fishers Lane, 08W05A Rockville, MD 20857 RE: HRSA 340B Drug Pricing Program; Administrative Dispute Resolution Proposed Rule, HHS Docket…
AHA 340B Hospital Members Urged to Submit Comments on HRSA’s Proposed Rule on the 340B Administrative Dispute Resolution Process, Model Comment Letter Available
Memorandum Opinion: Granting in Part, Denying In Part Plaintiffs Motion to Hold Unlawful and Remedy Defendants’ Past Underpayments of 340b Drugs
As drug prices continue to rise, the 340B drug pricing program continues to help hospitals expand access to comprehensive health services, including lifesaving prescription drugs for those in need who may not be able to afford them, writes AHA President and CEO Rick Pollack in the Wall Street…
The U.S. District Court for the District of Columbia today decided to allow the Department of Health and Human Services to propose an appropriate remedy for its past underpayments to hospitals participating in the 340B drug pricing program
For more than five years, the Department of Health and Human Services has unlawfully withheld vital funding from 340B hospitals that helps them provide a range of important benefits to their patients and communities. We are disappointed that the district court elected to extend this delay by…
The U.S. District Court for the District of Columbia today decided to allow the Department of Health and Human Services to propose an appropriate remedy for its past underpayments to hospitals participating in the 340B Drug Pricing Program.
For 30 years, the 340B drug pricing program has helped eligible hospitals offer a wide range of important programs and services that benefit patients and advance health within their communities.
The convening of the 118th Congress this week is a reminder of Washington’s highly-charged political environment.